BASEL, Switzerland - Novartis AG on April 24 said it has received a subpoena from the U.S. Attorney's Office for the District of Massachusetts for documents relating to alleged quality issues at the company's Emeryville and Vacaville facilities in California "in relation to antigens."...(read more)![]()
↧